📰 Biontech Se News
Page 13 - Biontech Se News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Biontech Se. Real-time updates on events, politics, business and more.
September 1, 2022
Investegate announcements from BioNTech SE, Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
August 31, 2022
Investegate announcements from BioNTech SE, Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
August 23, 2022
Investegate announcements from BioNTech SE, Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
August 22, 2022
Data support request for Emergency Use Authorization of a 30-µg booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals 12...
August 22, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
August 5, 2022
Investegate announcements from BioNTech SE, BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates
August 5, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
August 5, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
July 27, 2022
NEW YORK and MAINZ, Germany, July 27, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a...
July 27, 2022
Investegate announcements from BioNTech SE, Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design